IMCR Earnings

IMCR reported its FY2025Q3 earnings on 2025-11-06, showcasing a revenue of 103.69M against an estimate of 101.83M, resulting in a 1.83% surprise. The EPS was 0, surpassing the expected -0.3 by 100%. The stock experienced a 2.58% price change on the earnings day and a 14.29% change over the next five days, reflecting market reactions to the results.

Following IMCR's FY2025Q3 earnings announcement on 2025-11-06, the stock price moved by 2.58% on the day of the release. Over the subsequent five days, it saw a 14.29% change. Historically, IMCR's stock price tends to shift by an average of -0.36% in the 10 days leading up to earnings and -2.87% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate IMCR's annual revenue to reach 109.60M, while the EPS is projected at -0.10. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between IMCR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IMCR's stock price typically moves by -0.36% in the 10 days before its earnings and -2.87% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.10 and revenue of 109.60M.

The earnings call highlights a mixed outlook. Positive factors include strategic focus on outpatient assets, significant opportunity in Canada, and plans to reduce debt. However, the European asset sale did not meet pricing expectations, and there's no clear guidance on FFO per share. The company is undergoing a transformation, but uncertainties remain, such as unclear management responses and potential dilution from equity raises. Given the market cap of approximately $1.7 billion, these mixed signals suggest a neutral stock price movement in the short term.